| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers I > Headlines for Icahn Enterprises LP > News item |
Icahn Enterprises tenders for Vivus’ 4.5% convertible notes due 2020
New York, Sept. 9 – Icahn Enterprises LP announced a cash tender offer for the 4.5% convertible senior notes due 2020 issued by Vivus, Inc.
Icahn Enterprises is offering $680 per $1,000 principal amount of the notes plus accrued interest up to but excluding the settlement date, according to a news release.
The offer ends at 5 p.m. ET on Oct. 7.
Under the terms of the offer, Icahn Enterprises will not be obliged to buy any notes unless at least a majority is tendered.
Icahn Enterprises is making the offer through its subsidiary IEH Biopharma LLC.
D.F. King & Co., Inc. (800 515-4507, banks and brokers call 212 269-5550) is information agent, and Continental Stock Transfer & Trust Co. (917 262-2378) is depositary.
Icahn Enterprises is a New York-based investment holding company. Vivus is a Mountain View, Calif.-based pharmaceutical company focused on treatments for obesity and sexual dysfunction.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.